DK0481294T3 - Fast, hurtigt-opløseligt lægemiddelpræparat indeholdende S-(carboxymethyl)-L-cystein og/eller N-acetylcystein - Google Patents

Fast, hurtigt-opløseligt lægemiddelpræparat indeholdende S-(carboxymethyl)-L-cystein og/eller N-acetylcystein

Info

Publication number
DK0481294T3
DK0481294T3 DK91116899.5T DK91116899T DK0481294T3 DK 0481294 T3 DK0481294 T3 DK 0481294T3 DK 91116899 T DK91116899 T DK 91116899T DK 0481294 T3 DK0481294 T3 DK 0481294T3
Authority
DK
Denmark
Prior art keywords
acetylcysteine
cysteine
carboxymethyl
fast
solid
Prior art date
Application number
DK91116899.5T
Other languages
English (en)
Other versions
DK0481294T4 (da
Inventor
Gerd Dr Birrenbach
Rolf-Dieter Juch
Christian Dr Pflugshaupt
Original Assignee
Spirig Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4253965&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0481294(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Spirig Ag filed Critical Spirig Ag
Publication of DK0481294T3 publication Critical patent/DK0481294T3/da
Application granted granted Critical
Publication of DK0481294T4 publication Critical patent/DK0481294T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK91116899T 1990-10-19 1991-10-04 Fast, hurtigt-opløseligt lægemiddelpræparat indeholdende N-acetylcystein DK0481294T4 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH334590 1990-10-19

Publications (2)

Publication Number Publication Date
DK0481294T3 true DK0481294T3 (da) 1995-11-27
DK0481294T4 DK0481294T4 (da) 2001-06-18

Family

ID=4253965

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91116899T DK0481294T4 (da) 1990-10-19 1991-10-04 Fast, hurtigt-opløseligt lægemiddelpræparat indeholdende N-acetylcystein

Country Status (7)

Country Link
US (1) US5401514A (da)
EP (1) EP0481294B2 (da)
AT (1) ATE125702T1 (da)
DE (1) DE59106133D1 (da)
DK (1) DK0481294T4 (da)
ES (1) ES2077757T5 (da)
GR (1) GR3017499T3 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1256616B (it) * 1992-12-02 1995-12-12 Zambon Spa Sciroppo contenente n-acetil-cisteina
US5807894A (en) * 1992-12-02 1998-09-15 Zambon Group S.P.A. Syrup containing N-acetyl-cysteine
GB9305058D0 (en) * 1993-03-12 1993-04-28 Penn Pharm Ltd Pharmaceutical compositions
SE9601527D0 (sv) * 1996-04-23 1996-04-23 Pharmacia Ab Transdermally alministered acetylcysteine as mucolytic agent
DE839528T1 (de) * 1996-10-29 1998-10-22 Staroil Ltd Mundlösliche Zusammensetzungen die N-Acetylcystein und Cyclodextrin enthalten
US6296868B1 (en) 1998-11-19 2001-10-02 Advanced Technology Pharmaceuticals Corporation Chewable tablets containing mannitol and aspartame
IT1311907B1 (it) * 1999-04-06 2002-03-20 Zambon Spa Compresse deglutibili ad alto contenuto di n-acetilcisteina.
AU2001294192A1 (en) * 2000-10-06 2002-04-22 Takeda Chemical Industries Ltd. Solid preparations
AU2002224053A1 (en) * 2000-11-21 2002-06-03 Kyorin Pharmaceutical Co. Ltd. Dry syrup preparations
AR032556A1 (es) * 2001-02-08 2003-11-12 Pharmacia Corp Medicamento de accion inmediata para el tratamiento de la disfuncion sexual
AU2003277296A1 (en) * 2002-10-04 2004-05-04 Pharmacia Corporation Compositions and methods for treating sexual dysfunction
US7282217B1 (en) 2003-08-29 2007-10-16 Kv Pharmaceutical Company Rapidly disintegrable tablets
US7790928B1 (en) * 2005-04-25 2010-09-07 Albert Raymond Hechinger Therapeutic dimethyl sulfoxide (aka DMSO) compositions and methods of use
CN102316730A (zh) * 2008-05-09 2012-01-11 天雅瑞药业有限公司 用于减轻全身性炎症和/或血管炎症的n-乙酰半胱氨酸(nac)的控释
US20100120776A1 (en) * 2008-11-12 2010-05-13 Hall Bioscience Corporation Carbocysteine medical foods
TR200900881A2 (tr) 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tadı ve kokusu maskelenmiş stabil farmasötik bileşimler
TR200900882A2 (tr) 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tadı ve kokusu maskelenmiş, bıyoyararlanımı yüksek farmasotık bileşimler.
US8293299B2 (en) 2009-09-11 2012-10-23 Kraft Foods Global Brands Llc Containers and methods for dispensing multiple doses of a concentrated liquid, and shelf stable Concentrated liquids
US11013248B2 (en) 2012-05-25 2021-05-25 Kraft Foods Group Brands Llc Shelf stable, concentrated, liquid flavorings and methods of preparing beverages with the concentrated liquid flavorings
ITMI20130874A1 (it) 2013-05-29 2014-11-30 Zambon Spa Compresse deglutibili di n-acetilcisteina
PT2886108T (pt) * 2013-12-23 2019-04-01 Dr Falk Pharma Gmbh Formulação farmacêutica otimizada para o tratamento de alterações inflamatórias do esófago
RU2611411C1 (ru) * 2016-01-11 2017-02-21 Общество с ограниченной ответственностью "Трейдсервис" Диспергируемая в воде таблетка ацетилцистеина и способ ее изготовления
CN108553439B (zh) * 2018-04-20 2020-10-16 广州白云山医药集团股份有限公司白云山制药总厂 一种含s-羧甲基-l-半胱氨酸的肠溶片剂
PH12018000390A1 (en) * 2018-11-20 2020-09-28 Novex Science Pte Ltd Carbocysteine and zinc tablet
US20220175851A1 (en) * 2019-03-13 2022-06-09 The Regents Of The University California Compositions, methods for regulating uterine, placental growth

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2437834A1 (fr) * 1978-10-04 1980-04-30 Lejeune Jerome Compositions pharmaceutiques a base de l-serine ou de glycine
HU180443B (en) * 1979-04-02 1983-03-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing a pharmaceutical preparation with synergetic action against radiation
NL8502092A (nl) * 1985-07-22 1987-02-16 Cedona Haarlemmer Pharma Tabletten die s-carboxymethylcysteine bevatten en werkwijze voor de bereiding daarvan.
EP0281200B1 (en) * 1987-03-02 1994-01-19 Yamanouchi Europe B.V. Pharmaceutical composition, pharmaceutical granulate and process for their preparation
IT1217445B (it) * 1988-04-29 1990-03-22 Altergon Sa Composizione farmaceutiche orosolubili contenti acetilcisteina
CH674940A5 (da) * 1988-05-05 1990-08-15 Ibsa Inst Biochimique Sa
SE462779B (sv) * 1988-10-10 1990-09-03 Lejus Medical Ab Farmaceutisk komposition innehaallande n-acetylcystein i en kaerna belagd med hydroxipropylmetylcellulosaftalat

Also Published As

Publication number Publication date
US5401514A (en) 1995-03-28
EP0481294B1 (de) 1995-08-02
EP0481294A1 (de) 1992-04-22
EP0481294B2 (de) 2001-04-11
ES2077757T3 (es) 1995-12-01
ATE125702T1 (de) 1995-08-15
DE59106133D1 (de) 1995-09-07
ES2077757T5 (es) 2001-06-01
GR3017499T3 (en) 1995-12-31
DK0481294T4 (da) 2001-06-18

Similar Documents

Publication Publication Date Title
DK0481294T3 (da) Fast, hurtigt-opløseligt lægemiddelpræparat indeholdende S-(carboxymethyl)-L-cystein og/eller N-acetylcystein
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
SE8804629A (da)
DK275488A (da) Indolonderivater
DE69006365D1 (de) Unbeschichtete pharmazeutische reaktionstablette.
DE69206876T2 (de) Nukleosidanalogen enthaltende Antiviren-Zubereitungen
DE68903605D1 (de) Kautablette.
SE8702941D0 (sv) Farmaceutisk, n-acetyl-cysteininnehallande, vattenloslig komposition
EA199900709A1 (ru) Таблетка для глотания, включающая в себя парацетамол
ES2062610T3 (es) Compuesto diarilico anti-ateroesclerotico.
PH27446A (en) Compound with gastric acid inhibitory effect
DE68902300D1 (de) Pharmazeutische loesung enthaltend salbutamol und cromoglycinsaeure.
ATA180191A (de) Furanderivate enthaltende pharmazeutische präparate
DE69023708T2 (de) Anti-hiv-heilmittel.
ATE81000T1 (de) Stabilisierte, n-acetylcysteinhaltige arzneimittelzubereitung.
DK166343C (da) Forbedret piroxicamholdigt laegemiddel
ATA124091A (de) Pharmazeutische präparation enthaltend eine thrombolytisch wirkende substanz
DE3265827D1 (en) Pharmaceutical composition of phosphonomicin in tablet form
IE872860L (en) Therapeutic compositions and use thereof
DK160388A (da) Tert-butylamino-3-(phenyl-2'-phenoxy)-1-propanol-2 og syreadditionssalte deraf til anvendelse som terapeutisk aktivt stof
RU92015628A (ru) Состав для дезинфекции объектов пчеловодства
RU92009797A (ru) Дезинфицирующий водный раствор для стоматологических оттисков
KR890003367A (ko) 심장질환 치료용 조성물